Holen Sie sich die Stockscreener-App
4.395
3.17%
0.135
Schlusskurs vom Vortag:
$4.26
Offen:
$4.29
24-Stunden-Volumen:
8,122
Relative Volume:
0.05
Marktkapitalisierung:
$90.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-102.09M
KGV:
-4.1857
EPS:
-1.05
Netto-Cashflow:
$-108.72M
1W Leistung:
+0.00%
1M Leistung:
-2.77%
6M Leistung:
-5.31%
1J Leistung:
-45.75%
1-Tages-Spanne:
$4.1633
$4.60
1-Wochen-Bereich:
$4.1633
$4.60
52-Wochen-Spanne:
$2.2045
$9.09
Dbv Technologies Adr Stock (DBVT) Company Profile
Firmenname
Dbv Technologies Adr
Sektor
Branche
Telefon
33(0)155427878
Adresse
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Vergleichen Sie DBVT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DBVT
Dbv Technologies Adr
|
4.395 | 90.17M | 0 | -102.09M | -108.72M | -1.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-04 | Hochstufung | Societe Generale | Hold → Buy |
| 2022-12-16 | Herabstufung | Goldman | Neutral → Sell |
| 2022-05-10 | Herabstufung | Goldman | Buy → Neutral |
| 2021-09-14 | Hochstufung | Societe Generale | Hold → Buy |
| 2021-01-22 | Herabstufung | Societe Generale | Hold → Sell |
| 2020-11-02 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-08-06 | Herabstufung | Societe Generale | Buy → Sell |
| 2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-17 | Herabstufung | Stifel | Buy → Hold |
| 2020-01-09 | Hochstufung | Stifel | Hold → Buy |
| 2019-12-16 | Eingeleitet | Citigroup | Buy |
| 2019-09-05 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-06-17 | Eingeleitet | Goldman | Buy |
| 2018-12-20 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-12-20 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2018-12-20 | Herabstufung | Jefferies | Buy → Hold |
| 2018-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2017-10-31 | Hochstufung | Societe Generale | Sell → Hold |
| 2017-10-24 | Herabstufung | Societe Generale | Buy → Sell |
| 2017-10-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2017-06-23 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-16 | Hochstufung | Societe Generale | Hold → Buy |
| 2016-09-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-03 | Eingeleitet | Barclays | Overweight |
| 2015-10-23 | Eingeleitet | BofA/Merrill | Buy |
Alle ansehen
Dbv Technologies Adr Aktie (DBVT) Neueste Nachrichten
European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading - MSN
DBV Technologies (NASDAQ:DBVT) Now Covered by StockNews.com - MarketBeat
DBV Technologies (NASDAQ:DBVT) Stock Crosses Above 50-Day Moving AverageTime to Sell? - MarketBeat
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - TradingView
DBV Technologies stock holds firm with $10 target from JMP By Investing.com - Investing.com South Africa
DBV Technologies stock holds firm with $10 target from JMP - Investing.com India
DBV Technologies (NASDAQ:DBVT) Shares Cross Above Fifty Day Moving Average – Time to Sell? - Defense World
DBV Technologies (NASDAQ:DBVT) Coverage Initiated at StockNews.com - MarketBeat
DBV Technologies (NASDAQ:DBVT) Now Covered by Analysts at StockNews.com - Defense World
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, End Week Up 3.2% - TradingView
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading - TradingView
European Equities Traded in the US as American Depositary Receipts Tread Water in Monday Trading - MSN
DBV Technologies (NASDAQ:DBVT) Shares Cross Above 50-Day Moving AverageShould You Sell? - MarketBeat
StockNews.com Begins Coverage on DBV Technologies (NASDAQ:DBVT) - Defense World
Patch effective through 36 months in treating toddlers with peanut allergy - Healio
DBV Technologies (NASDAQ:DBVT) Coverage Initiated by Analysts at StockNews.com - Defense World
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - MSN
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF - The Manila Times
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - MSN
DBV Technologies Reports H2 2024 Liquidity Contract Results: 440,957 Shares Traded - StockTitan
JMP Securities Reiterates “Market Outperform” Rating for DBV Technologies (NASDAQ:DBVT) - Defense World
DBV Technologies' SWOT analysis: peanut allergy patch maker's stock faces pivotal year By Investing.com - Investing.com South Africa
DBV Technologies' SWOT analysis: peanut allergy patch maker's stock faces pivotal year - Investing.com India
DBV Technologies' (DBVT) Market Outperform Rating Reiterated at JMP Securities - MarketBeat
StockNews.com Initiates Coverage on DBV Technologies (NASDAQ:DBVT) - Defense World
DBV Technologies Reports Positive Phase 3 Study Results - TipRanks
DBV Technologies announces three-year results from EPITOPE trial - TipRanks
DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study - The Manila Times
DBV's VIASKIN Peanut Patch Shows Breakthrough 83.5% Success Rate in Toddler Study - StockTitan
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Flat for Week - MSN
DBV Technologies (NASDAQ:DBVT) Share Price Crosses Below 50 Day Moving AverageWhat's Next? - MarketBeat
European Equities Traded in the US as American Depositary Rise in Monday Trading - MSN
European Equities Traded in the US as American Depositary Rise in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Edge Lower in Thursday Trading - MSN
European Equities Traded in US as American Depositary Receipts Tread Water Friday, Up 3% for Week - MSN
Finanzdaten der Dbv Technologies Adr-Aktie (DBVT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dbv Technologies Adr-Aktie (DBVT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mohideen Pharis | Chief Medical Officer |
Nov 25 '24 |
Sale |
0.57 |
565 |
322 |
111,110 |
| Mohideen Pharis | Chief Medical Officer |
Nov 22 '24 |
Sale |
0.53 |
342 |
181 |
111,675 |
| Mohideen Pharis | Chief Medical Officer |
Nov 21 '24 |
Sale |
0.54 |
2,350 |
1,269 |
112,017 |
| Mohideen Pharis | Chief Medical Officer |
Jul 29 '24 |
Sale |
0.98 |
1,785 |
1,749 |
79,367 |
| Mohideen Pharis | Chief Medical Officer |
May 24 '24 |
Sale |
1.36 |
660 |
898 |
81,152 |
| Mohideen Pharis | Chief Medical Officer |
May 22 '24 |
Sale |
1.38 |
382 |
527 |
81,812 |
| Tasse Daniel | CHIEF EXECUTIVE OFFICER |
Mar 08 '24 |
Buy |
0.83 |
17,094 |
14,188 |
17,094 |
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):